Heart failure (HF) = common + underrecognized in patients with MASLD. pubmed.ncbi.nlm.nih.gov/40389356/ ✴️ Key findings: ~50% of biopsy-proven MASLD patients suspected to have HF, but only ~20% diagnosed. ➡️ Risk stratification and screening needed! @fudimmarat.bsky.social

🚨 Calling all #HeartFailure friends and colleagues Our 1⃣st Devices in Heart Failure day at #HFSA 🔬Mechanisms,💡Implementation, 🖐️Hands on 📅 Sep 26 Minneapolis Details: hfsa.org/asm/hfsa-dev... Special Events:⭐️Trial Tinder and ♥️Heart Tank Apply➡️ shorturl.at/qtyn2

Last week, I sat down with @fudimmarat.bsky.social and Rishi Trivedi (@smidtheart.bsky.social) at #ACC25 to talk about interventional heart failure training and how the paradigm is shifting for @tctmd.bsky.social's #FellowsForum. www.tctmd.com/videos/forma...

The emerging subspecialty of interventional HF could help fill the gap in trained physicians available to treat an increasingly complex group of pts, experts argue in a new consensus doc @fudimmarat.bsky.social @richardcheng.bsky.social @scainews.bsky.social #CardioSky www.tctmd.com/news/it-time...

In chapter 1 (⏲️01:25) Michael talks w/ @fudimmarat.bsky.social on the evolving landscape of device-based therapies for #heartfailure treatment and the need for more #clinicaltrials to integrate devices alongside #GMDT. 🔗Full statement, Top 10 Takeaways and Quick Highlights bit.ly/4fwBBMh